Hydroxychloroquine is available as the brand-name drug Plaquenil. Generic drugs usually cost less than the brand-name version. Hydroxychloroquine may be used as part of a combination therapy. Optometric testing for plaquenil toxicity Plaquenil and sulfasalazine According to the American College of Rheumatology, hydroxychloroquine Plaquenil, is a “disease-modifying anti-rheumatic drug DMARD,” meaning that it helps reduce the pain and swelling that come with arthritis. It can also reduce the incidence of joint damage. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis a 24-week randomized controlled open label study. Ravindran V12, Alias G3. Author information 1Department of Rheumatology, PVS Hospital, Calicut, India. [email protected] Specific Management of Post-Chikungunya Rheumatic Disorders A Retrospective Study of 159 Cases in Reunion Island from 2006-2012 Emilie Javelle, 1, * Anne Ribera, 2 Isabelle Degasne, 3 Bernard-Alex Gaüzère, 4 Catherine Marimoutou, 5 and Fabrice Simon 1, * Hydroxychloroquine is used to treat lupus erythematosus and rheumatoid arthritis. It isn’t fully understood how this drug works to treat lupus erythematosus or rheumatoid arthritis. That means you may need to take it with other drugs. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine in chikungunya Post-chikungunya chronic arthritis--our experience with DMARDs over two., Efficacy of combination DMARD therapy vs. hydroxychloroquine. Sulfa in plaquenilBob & aralene goldberg foundationHydroxychloroquine for rheumatoid arthritis reviews Hydroxychloroquine oral tablet is available as a brand-name drug and a generic drug. Brand name Plaquenil. Hydroxychloroquine comes only as a tablet you take by mouth. Hydroxychloroquine is used to treat malaria, lupus erythematosus, and rheumatoid arthritis. Hydroxychloroquine Side Effects, Dosage, Uses, and More. Specific Management of Post-Chikungunya Rheumatic.. Rheumatic manifestations of chikungunya emerging concepts and.. OBJECTIVE Chikungunya virus infection is a rapidly emerging global viral infection that can cause chronic, debilitating arthritis that in some ways mimics rheumatoid arthritis. The aim of this study was to evaluate the available evidence regarding the efficacy and safety of methotrexate MTX, a therapy that is widely used in rheumatoid. Indian Journal of Rheumatology 2008 September Original Article Volume 3, Number 3; pp. 93–97 Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis a 16 week study S Pandya ABSTRACT Objective To study the clinical profile of patients of chronic chikungunya arthritis presenting to a rheumatology OPD in the Western part of India and to judge the treatment response to the disease modifying drugs methotrexate and hydroxychloroquine used to treat them. Provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.